C
Chee H. Ng
Researcher at St. Vincent's Health System
Publications - 363
Citations - 10688
Chee H. Ng is an academic researcher from St. Vincent's Health System. The author has contributed to research in topics: Medicine & Mental health. The author has an hindex of 35, co-authored 313 publications receiving 6699 citations. Previous affiliations of Chee H. Ng include University of Melbourne & Harvard University.
Papers
More filters
Journal ArticleDOI
High impact child abuse may predict risk of elevated suicidality during antidepressant initiation
TL;DR: If these findings are replicated in larger samples, child abuse history could become an important element of assessing risk benefit balance when initiating antidepressants and may help guide the level of patient review needed during antidepressant initiation.
Journal ArticleDOI
Psychiatric education and training in Asia.
Bruce Singh,Chee H. Ng +1 more
TL;DR: Formal postgraduate programmes in Indonesia, Thailand, Philippines, Singapore and India, and the long hard road of re-establishing psychiatric training in Cambodia following the tragedy of the Pol Pot era are described are described.
Journal ArticleDOI
Suicidality and clinical correlates in Chinese men who have sex with men (MSM) with HIV infection
Yuan Yuan Wang,Min Dong,Qinge Zhang,Dan Dan Xu,Jin Zhao,Chee H. Ng,Gabor S. Ungvari,Fu-Jun Jia,Yu-Tao Xiang +8 more
TL;DR: Suicidality is common in Chinese MSM with HIV infection and there is an urgent need to develop comprehensive suicide prevention program and mental health services for this population.
Journal ArticleDOI
Psychopathology and extrapyramidal side effects in smoking and non-smoking patients with schizophrenia: Systematic review and meta-analysis of comparative studies.
Hui Huang,Min Dong,Ling Zhang,Bao-Liang Zhong,Chee H. Ng,Gabor S. Ungvari,Zhen Yuan,Xiangfei Meng,Yu-Tao Xiang +8 more
TL;DR: It was found that smoking schizophrenia patients had more severe positive symptoms but less severe EPSE than non‐smoking patients.
Journal ArticleDOI
Adjunctive low-dose docosahexaenoic acid (DHA) for major depression: An open-label pilot trial.
TL;DR: Within the major limits of this open-label pilot study, the results suggest that DHA may provide additional adjunctive benefits in patients with mild- to -moderate depression.